SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-008016
Filing Date
2017-11-02
Accepted
2017-11-02 16:23:33
Documents
57
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vygr-20170930x10q.htm 10-Q 1645864
2 EX-31.1 vygr-20170930ex311002dfe.htm EX-31.1 20015
3 EX-31.2 vygr-20170930ex31293915d.htm EX-31.2 20083
4 EX-32.1 vygr-20170930ex3217e18eb.htm EX-32.1 15415
5 GRAPHIC vygr20170930x10q001.jpg GRAPHIC 88899
  Complete submission text file 0001558370-17-008016.txt   6460898

Data Files

Seq Description Document Type Size
6 EX-101.INS vygr-20170930.xml EX-101.INS 1405773
7 EX-101.SCH vygr-20170930.xsd EX-101.SCH 45350
8 EX-101.CAL vygr-20170930_cal.xml EX-101.CAL 49898
9 EX-101.DEF vygr-20170930_def.xml EX-101.DEF 168540
10 EX-101.LAB vygr-20170930_lab.xml EX-101.LAB 378826
11 EX-101.PRE vygr-20170930_pre.xml EX-101.PRE 294414
Mailing Address 75 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 75 SIDNEY STREET CAMBRIDGE MA 02139 857-259-5340
Voyager Therapeutics, Inc. (Filer) CIK: 0001640266 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37625 | Film No.: 171172716
SIC: 2836 Biological Products, (No Diagnostic Substances)